Quang X. Pham, Chairman, CEO and Interim CFO: Cadrenal Therapeutics CVKD Sell · Filed 06/18

Trade details

Type: Insider sale
Amount: $11,489.34
Shares · price: 3,613 sh · $3.18 a share
Held after: 129,102 sh
Stock: Cadrenal Therapeutics CVKD
Person: Quang X. PhamChairman, CEO and Interim CFO
Trade date: 26/06/16
Filed: 26/06/18
Days to filing: 2 days

Sold 2.7% of holdings

Share of holding sold: 2.7%

Cadrenal Therapeutics trades, last 26 weeks

What else happened in Cadrenal Therapeutics around then

Filed or reported within 30 days of the trade day · 05/17~07/16

Quang X. Pham's recent trades

Quang X. PhamChairman, CEO and Interim CFO
Sell10b5-1 planCadrenal Therapeutics
Sell10b5-1 plan
Cadrenal Therapeutics
CVKD
$27.5K
9,029 sh
$27.5K
Filed 06/26
Traded 06/26
Quang X. PhamChairman, CEO and Interim CFO
Sell10b5-1 planCadrenal Therapeutics
Sell10b5-1 plan
Cadrenal Therapeutics
CVKD
$6,381
2,127 sh
$6,381
Filed 06/26
Traded 06/25
Quang X. PhamChairman, CEO and Interim CFO
Sell10b5-1 planCadrenal Therapeutics
Sell10b5-1 plan
Cadrenal Therapeutics
CVKD
$32.5K
9,167 sh
$32.5K
Filed 06/24
Traded 06/22
Quang X. PhamChairman, CEO and Interim CFO
Sell10b5-1 planCadrenal Therapeutics
Sell10b5-1 plan
Cadrenal Therapeutics
CVKD
$7,286
2,277 sh
$7,286
Filed 06/24
Traded 06/23
Quang X. PhamChairman, CEO and Interim CFO
Sell10b5-1 planCadrenal Therapeutics
Sell10b5-1 plan
Cadrenal Therapeutics
CVKD
$1,621
513 sh
$1,621
Filed 06/18
Traded 06/17